These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35806087)

  • 1. Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration.
    Barbanente A; Gandin V; Ceresa C; Marzano C; Ditaranto N; Hoeschele JD; Natile G; Arnesano F; Pacifico C; Intini FP; Margiotta N
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands.
    Margiotta N; Savino S; Marzano C; Pacifico C; Hoeschele JD; Gandin V; Natile G
    J Inorg Biochem; 2016 Jul; 160():85-93. PubMed ID: 26775068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of lipophilic kiteplatin Pt(iv) prodrugs in PLGA-PEG micelles.
    Margiotta N; Savino S; Denora N; Marzano C; Laquintana V; Cutrignelli A; Hoeschele JD; Gandin V; Natile G
    Dalton Trans; 2016 Aug; 45(33):13070-81. PubMed ID: 27094010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
    ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR investigation of the spontaneous thermal- and/or photoinduced reduction of trans dihydroxido Pt(IV) derivatives.
    Petruzzella E; Margiotta N; Ravera M; Natile G
    Inorg Chem; 2013 Mar; 52(5):2393-403. PubMed ID: 23414056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum(IV) Complexes of
    Papadia P; Micoli K; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy.
    Curci A; Gandin V; Marzano C; Hoeschele JD; Natile G; Margiotta N
    Inorg Chem; 2017 Jul; 56(13):7482-7493. PubMed ID: 28636387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
    Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
    J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
    Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y
    Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects.
    Tabrizi L; Thompson K; Mnich K; Chintha C; Gorman AM; Morrison L; Luessing J; Lowndes NF; Dockery P; Samali A; Erxleben A
    Mol Pharm; 2020 Aug; 17(8):3009-3023. PubMed ID: 32628022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA fragment conformations in adducts with Kiteplatin.
    Margiotta N; Petruzzella E; Platts JA; Mutter ST; Deeth RJ; Ranaldo R; Papadia P; Marzilli PA; Marzilli LG; Hoeschele JD; Natile G
    Dalton Trans; 2015 Feb; 44(8):3544-56. PubMed ID: 25144401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    J Cancer Res Clin Oncol; 1994; 120(7):409-14. PubMed ID: 8188734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cisplatin resistance in human gastric cancer cells by a wogonin-conjugated Pt(IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB pathways.
    Chen F; Qin X; Xu G; Gou S; Jin X
    Biochem Pharmacol; 2017 Jul; 135():50-68. PubMed ID: 28288821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity.
    Barbanente A; Iacobazzi RM; Azzariti A; Hoeschele JD; Denora N; Papadia P; Pacifico C; Natile G; Margiotta N
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34200051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
    Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions with DNA Models of the Oxaliplatin Analog (
    Barbanente A; Papadia P; Di Cosola AM; Pacifico C; Natile G; Hoeschele JD; Margiotta N
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
    Savino S; Gandin V; Hoeschele JD; Marzano C; Natile G; Margiotta N
    Dalton Trans; 2018 May; 47(21):7144-7158. PubMed ID: 29766157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
    Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
    Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.